Focal adhesion kinase (FAK) is overexpressed and hyperactivated in triple-negative breast cancer, driving tumor aggressiveness and cancer stem cell-mediated therapy resistance. The gene discussed is PTK2; the disease is triple-negative breast carcinoma.